FDARulemakingFDA-2023-N-2177

Who commented on this docket

Medical Devices; Laboratory Developed Tests

3 organizations filed 3 public comments on Medical Devices; Laboratory Developed Tests, at the Food and Drug Administration. The comment window closed 967d ago.

Organizations
3
Comments
3
RIN
Comment window
closed 967d ago

Abstract

The Food and Drug Administration is proposing to amend its regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act including when the manufacturer of the IVD is a laboratory. We are also proposing a policy intended to phase out our general enforcement discretion approach for laboratory developed tests (LDTs) so that IVDs manufactured by laboratories would generally fall under the same enforcement approach as other IVDs. This phaseout is intended to better protect the public health by helping assure the safety and effectiveness of LDTs and may foster innovation.

Commenters (3)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.